Status:
COMPLETED
Measuring Corneal Cells With Specular Microscopy
Lead Sponsor:
Retina Institute of Hawaii
Conditions:
Retinal Diseases
Eligibility:
All Genders
50+ years
Brief Summary
Assess changes in the corneal cell count using Specular Microscopy following tretments with Anti-VEGF injections
Detailed Description
Patients with active Wet AMD often receive intraocular Anti-VEGF injections such as Macugen, Lucentis and Avastin on a monthly basis for an extended period of time. While these medications are very ef...
Eligibility Criteria
Inclusion
- Wet Age-related Macular Degeneration
- Receiving monthly intraocular injections of Anti-VEGF medication for at least 3 months
- Age greater than 50 years of age
Exclusion
- experiences adverse events
Key Trial Info
Start Date :
August 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01792154
Start Date
August 1 2012
End Date
November 1 2012
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Retina Institute of Hawaii
Honolulu, Hawaii, United States, 96815